778 results on '"Itzykson, Raphael"'
Search Results
2. Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways
3. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
4. Treatment Algorithm of CMML and Other Adult MDS/MPN Subtypes
5. Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
6. Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis
7. LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
8. P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia
9. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation
10. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
11. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
12. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
13. Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
14. Prognostic Factors in AML
15. Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML
16. Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.
17. The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
18. Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes
19. Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
20. Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
21. PitViper: a software for comparative meta-analysis and annotation of functional screening data
22. Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm
23. A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia
24. A multiparametric niche-like drug screening platform in acute myeloid leukemia
25. Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
26. Contemporary treatment approaches to CMML – Is allogeneic HCT the only cure?
27. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
28. CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia
29. Targeting Heterochromatin Eliminates Malignant Stem Cells in Chronic Myelomonocytic Leukemia Through Reactivation of Retroelements and Innate Immune pathways
30. Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy
31. Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms
32. Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
33. Chronic Myelomonocytic Leukemia (CMML)
34. Prognostic Factors in AML
35. Clonal Dynamics of FLT3-ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin
36. Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders
37. AML-266 Optimization of a Drug Screening Platform in Acute Myeloid Leukemia
38. Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study
39. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
40. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
41. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
42. Clinical update on hypomethylating agents
43. Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML
44. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
45. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
46. Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
47. Novel precision medicine approaches and treatment strategies in hematological malignancies
48. P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
49. PB1769: STIM2, A CALCIUM CENSOR POTENTIALLY INVOLVED IN THE PATHOPHYSIOLOGY OF ACUTE MYELOID LEUKEMIA
50. How I treat chronic myelomonocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.